Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED)
Clinical trial NCT00087451 · COMPLETED
Trial details
- NCT number
- NCT00087451
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2005-11-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.